| Microarray cluster | 1 | 2 | 3 | 4 |
---|---|---|---|---|---|
Demographics | Age | 45.8 ± 9.3 | 46.9 ± 5.4 | 49.0 ± 7.4 | 45.0 ± 13.0 |
Disease duration | 13.6 ± 9.6 | 21.2 ± 3.31 | 17.3 ± 8.8 | 13.1 ± 9.2 | |
SLE disease activity/damage | SLEDAI-2 K | 8.7 ± 6.4 | 7.0 ± 3.8 | 2.0 ± 3.1 | 2.7 ± 2.4 |
SLICC/ACR-DI | 2.3 ± 2.3 | 4.0 ± 0.8 | 2.3 ± 1.6 | 0.7 ± 1.2 | |
Renal disease | 67.6% | 100% | 14.3% | 33.3% | |
Atherosclerosis | Atherosclerosis phenotype | 0% | 75.0% | 71.0% | 20.0% |
Carotid intima-media thickness | 0.53 | 0.69 | 0.72 | 0.59 | |
Carotid plaque | 0% | 75.0% | 57.1% | 33.3% | |
Coronary artery calcium score | 0 | 124 ± 85 | 349 ± 786 | 103 ± 252 | |
Aortic calcium score | 0 | 2,638 ± 3,261 | 828 ± 995 | 89 ± 149 | |
Traditional cardiovascular risk factors | 0 | 33.3% | 25% | 28.6% | 66.7% |
1 | 66.7% | 25% | 14.3% | 16.7% | |
2 | 0% | 25% | 28.6% | 16.7% | |
3 | 0% | 25% | 28.6% | 0% | |
Average number of risk factors | 0.7 | 1.5 | 1.6 | 0.5 | |
Current medication use | Steroids | 33.3% | 75.0% | 28.6% | 0.0% |
Hydroxychloroquine | 100% | 75.0% | 71.4% | 33.3% | |
Immunosuppressants | 33.3% | 100% | 28.6% | 16.7% | |
Statins | 0% | 75.0% | 28.6% | 33.3% |